相关实验视频
Updated: Jun 10, 2025

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
新诊断的大型B细胞淋巴瘤的基因组特征,有或没有随后的疾病进展
Daniel J Landsburg1, Jennifer J D Morrissette2, Sunita D Nasta1
1Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
通过实验室测试检测到的大B细胞淋巴瘤 (LBCL) 的基因组特征可以预测治疗耐药性. 这些特征也可以指导复发或耐药疾病患者的未来疗法.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 临床诊断 临床诊断 临床诊断
背景情况:
- 大型B细胞淋巴瘤 (LBCL) 是一种具有攻击性的血液性恶性瘤.
- 目前的一线治疗包括免疫化疗,但抗药性仍然是一个挑战.
- 识别预测生物标志物对于优化患者的治疗结果至关重要.
研究的目的:
- 研究通过临床试验检测到的LBCL的基因组特征是否可以预测对标准免疫化学疗法的耐药性.
- 探索这些基因组特征作为指导疾病进展患者随后治疗的生物标志物的潜力.
主要方法:
- 从LBCL患者样本中分析基因组资料.
- 特定基因组特征与对一线免疫化学疗法的反应的相关性.
- 评估基因组特征作为预测需要替代疗法的患者的结果.
主要成果:
- 在LBCL中发现的某些基因组特征与对初始免疫化学疗法的耐药性有关.
- 这些基因组标记物显示出预测患者对救援或新型治疗策略的反应的潜力.
结论:
- 在LBCL中基因组分析对预测治疗反应和指导治疗决策充满希望.
- 临床实验室检测基因组特征可以为LBCL患者提供个性化的治疗方法,特别是那些耐火性疾病患者.
更多相关视频
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...